Dr Craig Titmus is a UK & European Patent Attorney and Partner in the Life Sciences Team at Mathys & Squire
He has considerable experience within the life sciences sector and is recognised for his ability to work with technologically diverse subject matter. Craig has an enviable record in identifying and obtaining valuable patent protection, particularly in the fields of vaccines, diagnostics, therapeutic proteins and recombinant technologies.
Craig has an extensive European and international patent prosecution practice, and coordinates global IP portfolios for a range of clients including start-ups, SMEs, universities, large corporations and the UK government. Throughout his career, he has been responsible for establishing and developing IP portfolios that underpin a number of successful UK start-ups and SMEs.
Craig holds a bachelor’s degree in molecular biology and biochemistry, as well as a PhD in biotechnology. He works on a wide variety of technical subjects, specialising in the fields of biotechnology, biochemistry and life sciences. Craig is recommended in the latest edition of The Legal 500 for being ‘highly knowledgeable’ and noted for his ability to ‘consistently meet incredibly tight deadlines’. Craig, who ‘garners rave reviews for his life sciences adroitness’ is featured as a Recommended Individual in the 2019 edition of IAM Patent 1000, and is noted for being “a true strategic partner, helping clients far beyond the scope of their existing engagements.”
